Amneal Pharmaceuticals Inc (STU:2DT)
€ 14.9 +0.10 (+0.68%) Market Cap: 4.79 Bil Enterprise Value: 6.98 Bil PE Ratio: 44.55 PB Ratio: 0 GF Score: 61/100

Amneal Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 12:30AM GMT
Release Date Price: €11.3 (+1.80%)
Christopher Schott
JPMorgan Chase & Co - Analyst

Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Amneal today. From the company, we have the company's Co-CEO, Chirag Patel, who's going to be doing a presentation and then we're going to jump into a Q&A session from there. But Chirag, Happy New Year.

Chirag Patel
Amneal Pharmaceuticals Inc - President, Co-Chief Executive Officer, Co-Founder, Director

Thank you. Happy New Year, Chris. Thank you very much for joining us. At 4:30 today. But great to see you.

I'm very excited to be here. And thank you again, JPMorgan, for a wonderful conference here. So we're going to jump right into it. We have a lot to share and I'm going to start just a little history about the founding of Amneal, very humble beginning.

My brother is here as well. This time, he comes. We're co-CEOs, co-founders. Our father helped us with his knowledge and he's also a pharmaceutical scientist. And that's where our humble beginning started in 2002 in Paterson, New Jersey.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot